Category Patents/Designs/Trade Secrets

Annual Brussels IP Summit: Fresh Ideas In A Classic Context

BRUSSELS – In an age where technology and globalisation play an ever-increasing role, it must be asked whether the policy goals and structures of the intellectual property system remain relevant in Europe and beyond. In this regard, the newly elected “Junker Commission,” in office from 1 November, offers a chance to issue new IP strategies and strengthen the pre-existent IP infrastructures.

In light of such changes, the Pan-European Intellectual Property Summit (IP Summit) with its unique blend of keynote speakers and 25 workshops, running from reforms at the European and national levels to sectorial business practices across the spectrum of IP fields, provided once again a platform for fresh and critical ideas.

The Latest News In Intellectual Property From ANEPI Ecuador

Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Below is the list of the week's stories on ANEPI. Bienvenido a (ANEPI), La Primera Agencia de Noticias de Propiedad Intelectual del Ecuador: Síguenos http://www.anepi.ec/ANEPIEcuador

Will India, US Bridge Divide Over Intellectual Property Rights?

There is an uptick in India-United States relations. US President Barack Obama will be in India in January as the chief guest at the country’s Republic Day Parade. Obama, who hosted India’s new Prime Minister Narendra Modi in Washington in September, will become the first US president to attend such a celebration, a display of India’s military might and ethnic diversity, as well as the first to visit India twice while in office.

UN Office Of Drugs And Crime Enters Debate Over Fake Medicines And IP

The Vienna-based United Nations Office on Drugs and Crime (UNODC) has been working for several years to fight “fraudulent” medicines in the global supply chain. But an alleged new draft model legislation it is developing includes intellectual property rights, an issue which has led to intensive debates in other international fora. This week, a closed-door UNODC informal expert group drafting the model legislation is meeting in Vienna.

One Bite At The Apple: PTAB Closes IPR Joinder Loophole

As a result of the America Invents Act enacted three years ago, the United States Patent Trial and Appeal Board (PTAB) now handles inter partes reviews (IPR)—a new trial proceeding used to challenge the validity of patent claims based on patents and printed publications. Recently, the PTAB has caused a split concerning the proper scope of the IPR joinder provision, which grants the PTAB discretion to join a “party” to a previously-instituted IPR. In the past, the PTAB interpreted the term “party” expansively to include petitioners for whom it had already instituted an IPR. Petitioners were quick to jump on this loophole, and have since sought to raise new arguments in an instituted IPR by filing a subsequent petition and seeking joinder with the in-progress proceeding.

WIPO Seminar: For Access To Hepatitis C Treatments, Look At HIV Lessons

A seminar on innovation and access to medicine last week examined the issue of access to hepatitis C treatment, looking at the HIV/AIDS path. Voluntary licences, such as the one entered by Gilead for its hepatitis drugs, have been applauded but such licences often do not cover middle-income countries, which are home to the bulk of hepatitis C patients, and whose poor populations remain unable to access treatment.